Business
Putin says Russia, North Korea coordinating on regional security
Business
Cool Inflation Data Propels Stocks to Fresh Records
Prices on consumer and wholesale goods aren’t rising as much as feared, and that has been good for stock prices.
Two straight days of soft inflation data lifted the S&P 500 index to an all-time high. On Thursday, the Labor Department reported that wholesale prices were unchanged in July, defying predictions from economists who saw them rising. The reading, which followed a mellow consumer-price index print the day before, is resetting expectations about what the Federal Reserve will do next month—and in a positive way.
Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Business
SpaceX, Defense Contractors Progress On Orbital Interceptors, Pass Golden Dome Test
SpaceX, Northrop Grumman, Lockheed Martin and other key participants for the U.S. Golden Dome missile defense program have passed a critical milestone with their first round of tests as they compete for future contracts, the Space Force announced this week. Citi on Thursday hiked its price targets across its aerospace and defense coverage. U.S. Space Force Gen. Michael Guetlein, czar…
Copyright ©2026 Investor’s Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8
Business
Applied Materials Tops Views With Fiscal Q3 Results, Outlook
Applied Materials (AMAT) late Thursday beat analyst estimates for its fiscal third quarter and with its guidance for fiscal Q4. But AMAT stock slid in extended trading. The semiconductor equipment giant earned an adjusted $3.50 a share on sales of $9.12 billion in the quarter ended July 26. Analysts polled by FactSet had expected earnings of $3.40 a share on…
Copyright ©2026 Investor’s Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8
Business
BioRestorative Therapies suspends shipments of ExoCR and BioX products for review

BioRestorative Therapies suspends shipments of ExoCR and BioX products for review
Business
Nvidia, Stock Of The Day, Nears Buy Point Before Fiscal Q2 Earnings Report
NVIDIA NVIDIA NVDA $ 225.47 $0.17 0.07% 35% IBD Stock Analysis NVDA eyeing 236.54 buy point, with 224.76 early entry Stock recovering faster than other chip/AI hardware names Relative Strength line off highs, but highest in a few months IBD Composite Rating 97/99 Industry Group Ranking 15/197 Emerging Pattern Consolidation Consolidation A sideways pattern that doesn’t fit traditional base definitions.…
Copyright ©2026 Investor’s Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8
Business
Bruker declares $0.05 quarterly dividend for common shareholders

Bruker declares $0.05 quarterly dividend for common shareholders
Business
CoreCivic director Thurgood Marshall Jr. sells $241,400 in shares

CoreCivic director Thurgood Marshall Jr. sells $241,400 in shares
Business
Aehr Test Systems director Howard Slayen sells $758,264 in stock

Aehr Test Systems director Howard Slayen sells $758,264 in stock
Business
Ackman Calls Pershing Square USA’s Trailing Stock Price ‘Absurd’
Billionaire investor Bill Ackman held his first earnings call Thursday since he staged a simultaneous public listing of a new fund, Pershing Square USA, known by its ticker PSUS, and his management company, Pershing Square. Ackman told analysts that he was unhappy with the “frankly absurd” way in which shares in PSUS are trading. Most closed-end funds trade at a discount to the value of their underlying positions, but PSUS is an outlier. Its 22% discount was one of the widest of any U.S. closed-end fund that invested in public securities, according to the fund’s semiannual report.
Ackman said an active marketing program for PSUS would begin shortly with the goal of generating demand for the fund, especially among financial advisers, and narrowing the discount. Ackman told shareholders they could help by spreading the word. He also said he plans to launch a fund focused on venture investments. Read more:
Business
Oruka Therapeutics GC Paul Quinlan sells $5.64m stock

Oruka Therapeutics GC Paul Quinlan sells $5.64m stock
-
Fashion9 hours agoWeekend Open Thread: Ann Taylor
-
News Videos7 days agoCan Astrology Help Find Gold and Silver Trends? A Financial Astrology Guide
-
Business6 days agoDatadog: Best Of Breed For Multiple Reasons
-
Business6 days agoHow to Start a Cleaning Business: A Step-by-Step Guide
-
Business6 days agoBDC Weekly Review: Private BDC Q2 Numbers Are Strong
-
Business4 days agoOil Price Today (August 11): Crude oil rises to $88 after Trump’s compensation demand dents Hormuz opening. Here’s why
-
NewsBeat3 days agoCommunication cards help banking customers access services or report scams
-
Entertainment7 days ago10 R-Rated Drama Movies That Can Be Called Masterpieces
-
Fashion5 days agoAmazon Sundays: Closet Care Before Fall
-
Business7 days agoSharkNinja Keeps Eating
-
Politics6 days agoBe quiet, Miriam! – spiked
-
Business6 days ago5 Things You Must Know About Jorge Messi, the Father and Longtime Agent Who Shaped Lionel Messi’s Career
-
Business7 days agoMutual Fund Manager Scoops Up Beaten-Down Stocks
-
Crypto World4 days agoWhy Did Nvidia Stock Fall on Monday Despite a $500 Billion Wall Street AI Deal?
-
Politics5 days agoBen-Gvir’s crocodile project halted but abuses at Ketziot Prison continue
-
Politics5 days agoThe Church of England’s ruinous reparations racket
-
Politics7 days agoCalls to permanently pedestrianise central Belfast following festival success
-
Crypto World7 days agoBitcoin ETFs draw $853.5M in five-day inflow streak
-
Politics5 days agoSaudi Arabia used 86% of missile stockpile defending Iran attacks
-
Crypto World7 days agoA Deep Dive Into One Of The Most Significant Hacks In Recent Memory


You must be logged in to post a comment Login